Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Ozone Pharmaceuticals completed monolithic works at Ozone Medica

1/30/25 OZPH

MD Medical opened a clinic in Khabarovsk

1/30/25 MDMG

LSR invested ₽27 billion in the construction and renovation of two sanatoriums in Sochi

1/29/25 LSRG

Kamaz launches DFA on trucks

1/29/25 KMAZ

RusHydro may reduce dividends

1/29/25 HYDR

Sovcombank shareholders approved an additional share issue to merge with HCF Bank

1/29/25 SVCB

Henderson plans to grow 25% per year through 2028

1/29/25 HNFG

Astra's shipments in 2024 are up 78%

1/29/25 ASTR

INARCTICA's revenues in 2024 to grow by 10.5%

1/29/25 AQUA

Moscow Exchange to launch weekend trading at the end of Q2 2025

1/28/25 MOEX